Tricuspid Regurgitation Clinical Trials

Find Tricuspid Regurgitation Clinical Trials Near You

Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER

Status: Recruiting
Location: See all (13) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years at the time of consent.

• Severe symptomatic tricuspid regurgitation (TR) despite optimal medical therapy (OMT).

• Local site multidisciplinary heart team experienced in tricuspid valve therapies agrees that the subject is appropriate for TTVR.

Locations
United States
Alabama
University of Alabama at Birmingham (UAB) Hospital
RECRUITING
Birmingham
Arizona
Abrazo Arizona Heart Hospital
RECRUITING
Phoenix
California
Los Robles Hospital & Medical Center
RECRUITING
Thousand Oaks
Connecticut
Yale New Haven Hospital
RECRUITING
New Haven
Georgia
Emory University Hospital Midtown
RECRUITING
Atlanta
Illinois
Northwestern Memorial Hospital
RECRUITING
Chicago
Minnesota
Abbott Northwestern Hospital
RECRUITING
Minneapolis
New York
Buffalo General Medical Center
RECRUITING
Buffalo
Northwell Health North Shore University Hospital
RECRUITING
Manhasset
Montefiore Medical Center
RECRUITING
New York
NYU Langone Medical Center
RECRUITING
New York
Ohio
The Christ Hospital
RECRUITING
Cincinnati
Cleveland Clinic Foundation
RECRUITING
Cleveland
Contact Information
Primary
Amber St Martin
rs.pathfinder@medtronic.com
612-380-5637
Time Frame
Start Date: 2026-09-11
Estimated Completion Date: 2041-04
Participants
Target number of participants: 1186
Treatments
Experimental: Medtronic Intrepid™ TTVR
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.
Active_comparator: Edwards EVOQUE TTVR
Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.
Experimental: Single Arm Registry
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.
Related Therapeutic Areas
Sponsors
Leads: Medtronic Cardiovascular

This content was sourced from clinicaltrials.gov